Skip to main content

People in the News: Robert Wassman, Dganit Bar, David Suhy

Premium

Rosetta Genomics announced that it has named Robert Wassman as its new chief medical officer and Dganit Bar as its new chief scientific officer.

Wassman is a medical geneticist and has held various executive positions at companies including Genzyme Genetics. He most recently served as CMO at Generation Health.

Bar joins Rosetta from BioLineRx, where she served as executive director of science and technology. She also worked at QBI Enterprises, a subsidiary of Quark Pharmaceuticals.


Benitec Biopharma announced that Tacere Therapeutics' director of research and development, David Suhy, has been named its new senior vice president of research and development.

Suhy's appointment comes with Benitec's acquisition of Tacere.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.